serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.595 Phenol .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.253 Barbiturates .
D03.383.742.698.253.593 Pentobarbital .
D03.383.742.698.253.650 Phenobarbital .
HP4 Materia Medica .
HP4.018 Homeopathic Remedy .
HP4.018.592 Homeopathic Remedy P .
HP4.018.592.353 Phenobarbitalum .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Phenobarbital .
Gardenal .
Hysteps .
Luminal .
Phenobarbital Sodium .
Phenobarbital, Monosodium Salt .
Phenylethylbarbituric Acid .
Acid, Phenylethylbarbituric .
Monosodium Salt Phenobarbital .
Sodium, Phenobarbital .
Phenemal .
Phenobarbitone .
Phenylbarbital .
A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. .
1.00
17016651
 
Phenobarbitalum .
Gardenalum .
Homeopathic remedy. Gardenalum. Abbrev.: "phenob.". Chemical origin. Substance used: phenobartial. .
0.75
10
 
Phenol .
Carbol .
Carbolic Acid .
Hydroxybenzene .
Phenol, Sodium Salt .
Phenolate Sodium .
Sodium Phenolate .
Phenolate, Sodium .
An antiseptic and disinfectant aromatic alcohol. .
0.71
604458
 
Pentobarbital .
Diabutal .
Etaminal .
Ethaminal .
Nembutal .
Pentobarbital Sodium .
Pentobarbital, Monosodium Salt .
Pentobarbitone .
Sagatal .
Monosodium Salt Pentobarbital .
Mebubarbital .
Mebumal .
A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) .
0.68
779050